![Ross Levine](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ross Levine
Director/Board Member at
MEDICUS SCIENCES ACQUISITION CORP.
Net worth: 1 M $ as of 30/06/2026
Profile
Ross L.
Levine is the founder of Ajax Therapeutics, Inc., founded in 2019, serving as Director since its founding.
Current jobs include Independent Director at Medicus Sciences Acquisition Corp.
since 2021; Member of the Supervisory Board at QIAGEN NV since 2016; Member of the Supervisory Board at QIAGEN GmbH; Professor at Weill Cornell Medical College since 2007; and Member of the Supervisory Board at QIAGEN Srl.
Former jobs include Chief of Molecular Cancer Medicine Services at Memorial Sloan Kettering Cancer Center from 2018 to 2022 and Scientific Advisor at eFFECTOR Therapeutics, Inc. Education includes a doctorate from The Johns Hopkins University School of Medicine and an undergraduate degree from Harvard College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
QIAGEN NV 0.01% | 23/01/2026 | 27,495 ( 0.01% ) | 1 M $ | 30/06/2026 |
Ross Levine active positions
| Companies | Position | Start |
|---|---|---|
| MEDICUS SCIENCES ACQUISITION CORP. | Director/Board Member | 12/02/2021 |
QIAGEN GmbH
 QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services Provides products for preanalytical sample preparation and molecular diagnostics solutions | Director/Board Member | - |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2007 |
Qiagen SRL
 Qiagen SRL Medical SpecialtiesHealth Technology Provides molecular testing solutions | Director/Board Member | - |
Ajax Therapeutics, Inc.
 Ajax Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in R&D, clinical trial and manufactures hematologic cancer therapeutics | Founder | 01/01/2019 |
Former positions of Ross Levine
| Companies | Position | End |
|---|---|---|
| QIAGEN N.V. | Director/Board Member | 23/01/2026 |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates cancer hospital | Corporate Officer/Principal | - |
| EFFECTOR THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Training of Ross Levine
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
60
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
QIAGEN NV
 QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations | Health Technology |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates cancer hospital | Health Services |
QIAGEN GmbH
QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services Provides products for preanalytical sample preparation and molecular diagnostics solutions | Commercial Services |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Qiagen SRL
Qiagen SRL Medical SpecialtiesHealth Technology Provides molecular testing solutions | Health Technology |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ajax Therapeutics, Inc.
Ajax Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in R&D, clinical trial and manufactures hematologic cancer therapeutics | Commercial Services |
Medicus Sciences Acquisition Corp.
 Medicus Sciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
eFFECTOR Therapeutics, Inc.
 eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
- Stock Market
- Insiders
- Ross Levine
